https://www.selleckchem.com/pr....oducts/cilengitide-e
05). In the multivariate logistic regression model, at the 30-day follow-up, the Q4 (significantly increased NLR) group showed an elevated risk of poor outcomes (OR, 2.37; 95% CI, 1.17-4.83, P=0.02) and functional disability (OR, 2.21; 95% CI, 1.05-4.65, P=0.04). At the 3-month follow-up, the Q4 group still showed an elevated risk of poor outcomes (OR, 2.83; 95% CI, 1.38-5.77, P0.01) and functional disability (OR, 2.77; 95% CI, 1.28-5.98, P0.01). At the 1-year follow-up, the Q2 (slightly elevated NLR) g
Like
Comment
Share
